Related Experiment Video
Updated: Jun 6, 2025
12:02
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
27.2K
Miro1 expression alters global gene expression, ERK1/2 phosphorylation, oxidation, and cell cycle progression
Nathaniel Shannon1, Cory Raymond1, Chloe Palmer1
1Department of Pathology and Laboratory Medicine, University of Vermont Cancer Center, Larner College of Medicine, Burlington, VT 05405, USA.
Biorxiv : the Preprint Server for Biology
|November 22, 2024
Summary
Mitochondrial adaptor Miro1 is crucial for cell growth and cycle progression. Its absence disrupts mitochondrial trafficking, leading to altered ERK1/2 signaling and cell proliferation defects.
Area of Science:
- Cell Biology
- Mitochondrial Dynamics
- Molecular Signaling
Background:
- Mitochondrial positioning is vital for cellular energy and signaling.
- Miro1 facilitates mitochondrial trafficking via microtubule motor proteins.
- Miro1 deletion causes mitochondrial perinuclear sequestration and disrupted gradients.
Purpose of the Study:
- Investigate the impact of Miro1 deletion on MEF cell growth and cell cycle.
- Identify transcriptional changes associated with Miro1 deficiency.
- Elucidate the role of Miro1 in regulating ERK1/2 signaling pathways.
Main Methods:
- Comparative growth rate analysis of Miro1 knockout (Miro1-/-) and wild-type (Miro1+/+) MEFs.
- Cell cycle analysis using flow cytometry.
- RNA sequencing to assess gene expression changes in Miro1-/- MEFs.
- Western blotting and mass spectrometry to evaluate protein phosphorylation and oxidation states.
Main Results:
- Miro1-/- MEFs exhibit slower growth and a cell cycle defect (decreased G1, increased S phase).
- RNA sequencing reveals differential expression of cell proliferation, migration, and MAP Kinase signaling genes.
- ERK1/2 phosphorylation is elevated in Miro1-/- MEFs; DUSP1-6 expression and oxidation remain unchanged.
- Increased ERK1/2 oxidation is observed in Miro1-/- MEFs.
Conclusions:
- Miro1 is essential for normal cell proliferation and cell cycle progression.
- Miro1 deficiency impacts transcriptional regulation and MAPK signaling, specifically ERK1/2.
- Altered ERK1/2 signaling and oxidation in Miro1-/- MEFs may underlie observed cellular defects.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:07MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
02:15M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K